Biotech · Private company
Alopexx Oncology, LLC
Track this companyFree. Adds Alopexx Oncology, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- DI-Leu16-IL2Phase 2 · B-cell Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Participants With B-cell NHLPHASE1_PHASE2 · TERMINATED · started Nov 4, 2014ClinicalTrials.gov NCT02151903 · fetched Nov 12, 2026
- A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHLPHASE1_PHASE2 · TERMINATED · started Nov 25, 2013ClinicalTrials.gov NCT01874288 · fetched Nov 12, 2026